Is Sunshine Biopharma Inc. (SBFMW) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| DJIM | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| MSCI | 3.1% / 33% | 31.7% / 33% | 12.7% / 33% | 1.42% / 5% | ✓ HALAL |
| S&P | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| FTSE | 3.1% / 33% | 31.7% / 33% | 12.7% / 50% | 1.42% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 33.0% | |
| Operating Margin | -5.6% | |
| Net Margin | -16.1% | |
| Return on Equity (ROE) | -24.3% | |
| Return on Assets (ROA) | -9.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$13M |
| Free Cash Flow | -$15M |
| Total Debt | $952,480 |
| Debt-to-Equity | 3.5 |
| Current Ratio | 4.2 |
| Total Assets | $31M |
Price & Trading
| Last Close | $0.13 |
| Beta | 1.6 |
About Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Related Halal Stocks in
Frequently Asked Questions
Is Sunshine Biopharma Inc. (SBFMW) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Sunshine Biopharma Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Sunshine Biopharma Inc.'s debt ratio?
Sunshine Biopharma Inc.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.1%.
What are Sunshine Biopharma Inc.'s key financial metrics?
Sunshine Biopharma Inc. has a market capitalization of N/A, and revenue of $35M. The company maintains a gross margin of 33.0% and a net margin of -16.1%. Return on equity stands at -24.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.